1-13 of 13
Luca Trentin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The RNA Binding Protein Musashi-2 (MSI2) Sustains the Growth and the Leukemogenic Potential of MLL-Rearranged Acute Lymphoblastic Leukemia, and It Is Involved in Glucocorticoid Resistance

Luigia Valsecchi, Simone Naso, Simona Procopio, Mario Mauri, Rocco Piazza, Titus Watrin, Sanil Bhatia, Valentina Pasquale, Elena Sacco, Chiara Palmi, Grazia Fazio, Luca Trentin, Silvia Bresolin, Andrea Biondi, Giovanni Cazzaniga, Michela Bardini
Journal: Blood
Blood (2022) 140 (Supplement 1): 8827–8828.
https://doi.org/10.1182/blood-2022-166313
Published: 2022
Journal Articles

Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor

Vera Münch, Luca Trentin, Julia Herzig, Salih Demir, Felix Seyfried, Johann M. Kraus, Hans A. Kestler, Rolf Köhler, Thomas F. E. Barth, Geertruy te Kronnie, Klaus-Michael Debatin, Lüder H. Meyer
Journal: Blood
Blood (2017) 130 (5): 643–654.
https://doi.org/10.1182/blood-2017-03-769315
Published: 2017
Includes: Supplemental data
Journal Articles

Migration of Acute Lymphoblastic Leukemia Cells into the Central Nervous System Is Regulated By VEGF

Vera Muench, Luca Trentin, PhD, Julia Herzig, Johann Krauss, Hans A Kestler, Geertruy te Kronnie, Klaus-Michael Debatin, MDPhD, Lueder Hinrich Meyer, MD
Journal: Blood
Blood (2015) 126 (23): 2634.
https://doi.org/10.1182/blood.V126.23.2634.2634
Published: 2015
Journal Articles

Role of the Histone Deacetylase Inhibitor Givinostat (ITF2357) in Treatment of CRLF2 Rearranged Acute Lymphoblastic Leukemia

Angela Maria Savino, Jolanda Sarno, Luca Trentin, Margherita Vieri, Grazia Fazio, PhD, Michela Bardini, Cristina Bugarin, Gianluca Fossati, Kara L. Davis, DO, Giuseppe Gaipa, PhD, Lueder Hinrich Meyer, MD, Garry P. Nolan, Prof, PhD, Andrea Biondi, Prof, MD, Geertruy Te Kronnie, PhD, Chiara Palmi, PhD, Giovanni Cazzaniga
Journal: Blood
Blood (2015) 126 (23): 2534.
https://doi.org/10.1182/blood.V126.23.2534.2534
Published: 2015
Journal Articles

Leukemia Initiating Cells In Acute Lymphoblastic Leukemia Are Characterized By Low Metabolic Activity and Enriched In Early Cell Cycle

Luca Trentin, PhD, Manon Queudeville, MD, Sarah M Eckhoff, MD, Manuel Herrmann, Simone Miller, Sandra Lutz, Nabiul Hasan, Klaus-Michael Debatin, MD PhD, Lueder H Meyer, MD PhD
Journal: Blood
Blood (2013) 122 (21): 4197.
https://doi.org/10.1182/blood.V122.21.4197.4197
Published: 2013
Journal Articles

Overcoming Apoptosis Resistance In High Risk Acute Lymphoblastic Leukemia By Smac Mimetics In a Preclinical ALL Xenograft Model In Vivo

Melanie Schirmer, MD, Manon Queudeville, MD, Luca Trentin, PhD, Sarah M Eckhoff, MD, Lueder H Meyer, MD, PhD, Klaus-Michael Debatin, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1433.
https://doi.org/10.1182/blood.V122.21.1433.1433
Published: 2013
Journal Articles

CRLF2 Rearrangement Is Not Associated with Activated mTOR Pathway in NOD/SCID/huALL Xenograft Mouse Model.

Md. Nabiul Hasan, MSc, Silvia Bresolin, PhD, Ilaria Bronzini, PhD, Chiara Palmi, PhD, Manon Queudeville, MD, Sarah Mirjam Eckhoff, MD, Luca Trentin, PhD, Giovanni Cazzaniga, PhD, Geertury te Kronnie, PhD, Klaus-Michael Debatin, MD, PhD, Lüder-Hinrich Meyer, MD
Journal: Blood
Blood (2012) 120 (21): 2518.
https://doi.org/10.1182/blood.V120.21.2518.2518
Published: 2012
Journal Articles

Rapid BCP-ALL Engraftment in NOD/SCID Mice Is Characterized by a High Leukemia Initiating Cell (LIC) Frequency.

Luca Trentin, PhD, Manon Queudeville, MD, Sarah M. Eckhoff, MD, Felix Seyfried, Manuel Herrmann, Simone Miller, Nabiul Hasan, Klaus-Michael Debatin, MD, PhD, Lueder H. Meyer, MD
Journal: Blood
Blood (2012) 120 (21): 2985.
https://doi.org/10.1182/blood.V120.21.2985.2985
Published: 2012
Journal Articles

Hyperactivated mTOR Signaling Is a Characteristic Feature of High Risk Acute Lymphoblastic Leukemia and Can Be Effectively Targeted in a Preclinical NOD/SCID/huALL Xenograft Mouse Model

Md. Nabiul Hasan, MSc, Manon Queudeville, MD, Sarah Mirjam Eckhoff, MD, Manuel Herrmann, Simone Miller, Luca Trentin, PhD, Klaus-Michael Debatin, MD PhD, Lueder Hinrich Meyer, MD
Journal: Blood
Blood (2011) 118 (21): 2572.
https://doi.org/10.1182/blood.V118.21.2572.2572
Published: 2011
Journal Articles

Evolution of Sub-Clones with KRAS Mutations In Pediatric Patients with MLL-AF4 Rearrangements

Silvia Bresolin, Emanuela Giarin, Luca Trentin, PhD, Lueder Hinrich Meyer, MD, Giuseppe Basso, MD PhD, Geertruy Kronnie, PhD
Journal: Blood
Blood (2011) 118 (21): 2454.
https://doi.org/10.1182/blood.V118.21.2454.2454
Published: 2011
Journal Articles

Gene Expression Profile Analysis of Pediatric MDS Patients Correlates with FAB Classification and Has Prognostic Relevance

Silvia Bresolin, Luca Trentin, Geertruy Kronnie, PhD, Laura Sainati, MD, Marco Zecca, MD, PhD, Franco Locatelli, MD, PhD, Giuseppe Basso, MD
Journal: Blood
Blood (2008) 112 (11): 2695.
https://doi.org/10.1182/blood.V112.11.2695.2695
Published: 2008
Journal Articles

A New Subtype of Excellent Prognosis Identified by GEP in Childhood BCP-ALL Patients

Elena Vendramini, Marco Giordan, PhD, Silvia Bresolin, Luca Trentin, Andrea Zangrando, PhD, Giulia Fabbri, Geertruy Kronnie, PhD, Giuseppe Basso, MD
Journal: Blood
Blood (2008) 112 (11): 2513.
https://doi.org/10.1182/blood.V112.11.2513.2513
Published: 2008
Journal Articles

New Data on Robustness of Gene Expression Signatures in Leukemia: Comparison of Three Distinct Total RNA Preparation Procedures.

Marta Campo, Dell’Orto Graduate, Andrea Zangrando, Graduate, Luca Trentin, Graduate, Rui Li, PhD, Wei-min Liu, PhD, Geertruy te Kronnie, PhD, Giuseppe Basso, MD, Alexander Kohlmann, PhD
Journal: Blood
Blood (2006) 108 (11): 4288.
https://doi.org/10.1182/blood.V108.11.4288.4288
Published: 2006